Current management and future directions in metastatic pancreatic adenocarcinoma

Of the anticipated 50,000 individuals expected to be diagnosed with pancreatic cancer in 2016, the majority will have metastatic disease. Given the noncurative nature of advanced pancreatic adenocarcinoma, treatment is aimed at inducing disease regression, controlling symptom, and extending life. Th...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Cancer Jg. 122; H. 24; S. 3765 - 3775
Hauptverfasser:	Varghese, Anna M., Lowery, Maeve A., Yu, Kenneth H., O'Reilly, Eileen M.
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States 15.12.2016
Schlagworte:	Adenocarcinoma - drug therapy Animals Antineoplastic Combined Chemotherapy Protocols - therapeutic use chemotherapy Humans metastatic pancreatic cancer Pancreatic Neoplasms - drug therapy targets treatment standards pancreatic cancer treatment standards metastatic chemotherapy targets
ISSN:	0008-543X, 1097-0142
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!